G01N 2333/18
Togaviridae
Official title: Togaviridae; Flaviviridae
G01N2333/18 (Togaviridae) appears on 384 US grants and 592 published applications in this corpus.
Search patents in G01N- Granted patents
- 384
- Published applications
- 592
- Assignees
- 325
- Inventors
- 1,284
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 8 | 0 |
| 1999 | 6 | 0 |
| 2000 | 8 | 0 |
| 2001 | 6 | 2 |
| 2002 | 3 | 10 |
| 2003 | 8 | 19 |
| 2004 | 10 | 14 |
| 2005 | 7 | 23 |
| 2006 | 4 | 17 |
| 2007 | 14 | 21 |
| 2008 | 14 | 21 |
| 2009 | 12 | 21 |
| 2010 | 12 | 31 |
| 2011 | 10 | 24 |
| 2012 | 10 | 23 |
| 2013 | 14 | 17 |
| 2014 | 18 | 21 |
| 2015 | 15 | 32 |
| 2016 | 21 | 22 |
| 2017 | 20 | 31 |
| 2018 | 25 | 35 |
| 2019 | 27 | 36 |
| 2020 | 19 | 40 |
| 2021 | 21 | 36 |
| 2022 | 18 | 26 |
| 2023 | 16 | 16 |
| 2024 | 15 | 18 |
| 2025 | 6 | 21 |
| 2026 | 10 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for detecting virus using SSDNA functionalized sensor15 Sep 2026US 12,736,531 B2University of Central Florida Research Foundation, Inc.
- Zika/dengue vaccine and application thereof2 Jun 2026US 12,642,846 B2Institute of Microbiology, Chinese Academy of Sciences
- Methods for reducing electrode gap distances in electronic devices and resulting devices having nanometer electrode gaps via liquid phase molecular layer deposition technique2 Jun 2026US 12,644,858 B2University of Utah Research Foundation
- Antibodies which specifically bind to dengue virus serotype 4 (DENV4) non-structural protein 1 (NS1) and methods of use thereof to detect a DENV4 infection21 Apr 2026US 12,606,611 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods and compositions for the detection of host protein cleavage by group IV viral proteases21 Apr 2026US 12,607,633 B2The Government of the United States of America, as represented by the Secretary of the Navy
- Human antibodies targeting zika virus ns1, ns1 polypeptides and uses thereof10 Sep 2026US 2026/0266820 A1Icahn School of Medicine at Mount Sinai
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
- Nanobiosensor and preparation method thereof and virus antibody detection method using same13 Aug 2026US 2026/0235602 A1National Defense Medical University
- Micro-balance biosensors to detect whole viruses6 Aug 2026US 2026/0227361 A1University of Utah Research Foundation
- Methods, systems, and arrays for tickborne pathogen and disease analysis9 Jul 2026US 2026/0194522 A1Vibrant Holdings, LLC
Most cited
By later US patents
- Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity68US 6,117,639 AVertex Pharmaceuticals Incorporated · 2000
- 2′-branched nucleosides and Flaviviridae mutation59US 7,824,851 B2Idenix Pharmaceuticals, Inc. · 2010
- Porphyrin, azaporphyrin, and related fluorescent dyes free of aggregation and serum binding56US 5,641,878 ADiatron Corporation · 1997
- Fluorescent marker components and fluorescent probes52US 5,403,928 ADiatron Corporation · 1995
- Subunit immonogenic composition against dengue infection43US 6,165,477 AHawaii Biotechnology Group, Inc. · 2000